1. Home
  2. About Us
  3. History Timeline

History Timeline


Beginning from inception mid eighties, Pharmacare has scored significant landmarks throughout a dramatic journey of over 30 years:

Location

1985


Foundation charter

Location

1986


building of the manufacturing facility: The first Palestinian company to take into consideration GMP guidelines - The British “Orange” Guide.

Location

In November 1986


Amoxicare®, the first product produced by Pharmacare was introduced to the local market.

Location

1987

First international inspection by French experts. Pharmacare declared in the forefront of Palestinian companies in c-GMP guideline implementation.  

Location

1987


Established the first computer department as a separate entity in the company, ushering in the IT era into the Palestinian industry.

Location

1988

First computer network in the country was established at Pharmacare 

Location

1990


A strategic decision to expand internationally, with continuous local expansion in products and volumes.

Location

1990


  First American inspection by a former FDA inspector. PCP obtained an excellent assessment.

Location

1993


First shipment to Russia and Belarus. Pharmacare becomes the first company to export pharmaceuticals from Palestine. Currently Pharmacare is ranked no.12 in the Belarusian market.

Location

1999-2000


Pharmacare signed a joint venture agreement with Grunenthal GmbH of Aachen, Germany giving it 22% of Pharmacare’s share. 

Location

2000


Pharmacare inaugurated its state of the art multimillion-dollar manufacturing facility rendering it c-GMP compliant. Thus, Pharmacare is able to adhere to the continuously changing c-GMP guidelines, particularly implementing the zoning system which requires complete separation and independent access into production, packaging, labs and stores.

Location

2000


In the same year, Pharmacare received ISO 9001 and ISO 14000 certifications. 

Location

2000 - 2007


Pharmacare expanded its operations by introducing new therapeutic lines, diversifying the existing ones, and increasing its sales.

Location

November 2007


Pharmacare signed a supply agreement with Grunenthal GmbH to export Tramadol capsules to Germany.  Grunenthal will pack and sell the product in Germany and other EU countries. 

Location

December 2007


Pharmacare acquired the Palestinian Good Manufacturing Practices (GMP) after passing the official audit conducted by Ministry of Health and external experts.

Location

January 2008 (The Great Success)


Pharmacare is the 1st Palestinian pharmaceutical company to acquire the European GMP certificate.  This great success allowed Pharmacare to enter the European market, which enables further expansion of the company into an international establishment and benefiting the Palestinian economy by increasing the contribution to Palestinian GNP. …

Location

June 2008


 Pharmacare celebrated the first shipment of its medicine to Germany.

Location

February 2009


Pharmacare Premium project has officially been launched. The project consists of two facilities, one for packaging, testing and batch release of Pharmacare Palestine products and distributing the products for EU countries. The other facility is Oncology (Anti Cancer) product line.

Location

2010


 Large amounts of products were exported to the EU. By the end of 2010, about 41% of Pharmacare’s production was exported to European countries.

Location

October 2010


Pharmacare celebrated the official opening of Pharmacare Premium in Malta as the first Palestinian facility in EU.

Location

January 2011


Pharmacare successfully renewed its European c-GMP certificate for the coming 3 years. This great success reflects the ability of Pharmacare in maintaining excellence.

Location

February 2011

Pharmacare Premium acquired the EU GMP approval, and now as a certified facility, it is permitted to start operating as a batch release site.

Location

2012


Pharmacare PLC acquires the Latin American and Brazilian ‘’ANVISA-Granted’’ GMP.

Location

2013


 Renewal of EU-GMP

Location

2014


Renewal of the Palestinian GMP.

Location

2014 –2015


A new major expansion of Pharmacare’s facilities was initiated following approval of a long-term loan by the French Government. The ribbon cutting ceremony was held in September 2015 in the presence of the then French Minister of Economy and current president, Emanuel Macron. This expansion allows Pharmacare to introduce new production lines…

Location

2016


Palestinian GMP Renewal; Belarus GMP Renewal; EU-GMP Renewal

Location

2016 - 2017


Building professional relationships with the Polish Pol-Pharma in arrangement of both under-license and marketing authorisation holding agreements permitting the manufacturing of Pol-Pharma products in Palestine and the distribution of the Pharmacare products within a variety of European countries, respectively.

Location

2017


The establishment of the Soft Gel Facility functioning in the manufacturing of soft gel capsule medicinal products.

Location

2017


Renewal of the ISO 9001 and 14001 according to the 2015 guidelines and regulations

Location

2016 - 2018


Hikma-Care (HC): PCP is inaugurating a joint-venture with Hikma Pharmaceuticals manufacturing Hikma Pharmaceuticals’ products distributed within the West Bank and the Gaza Strip. 

Location

January 2018


The Iraqi Pharmaceutical Industry (IPI): A merging with Pharmacare constituting a 10% share, IPI comprises a manufacturing unit producing facility for conventional products in Iraq. 

Subscribe to PHARMACARE's newsletter

Copy ©2024 PharmaCare, All Rights Reserved